These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32665507)

  • 41. Fight COVID-19 Beyond the Borders: Emergency Department Patient Diversion in Taiwan.
    Lien WC; Wu JL; Tseng WP; Chow-In Ko P; Chen SY; Tsai MS; Chang WT; Huang CH; Chen SC
    Ann Emerg Med; 2020 Jun; 75(6):785-787. PubMed ID: 32334881
    [No Abstract]   [Full Text] [Related]  

  • 42. What works where in prevention of Covid-19: The case of Somalia.
    Gele A
    East Mediterr Health J; 2020 May; 26(5):495-496. PubMed ID: 32538439
    [No Abstract]   [Full Text] [Related]  

  • 43. COVID-19: leaving no one behind in Latin America.
    Blukacz A; Cabieses B
    Lancet; 2020 Oct; 396(10257):1070. PubMed ID: 33038968
    [No Abstract]   [Full Text] [Related]  

  • 44. The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Usuelli M
    Lancet; 2020 Nov; 396(10262):e86-e87. PubMed ID: 33069278
    [No Abstract]   [Full Text] [Related]  

  • 45. Infectious Disease Transmission Models to Predict, Evaluate, and Improve Understanding of COVID-19 Trajectory and Interventions.
    Buchwald AG; Adams J; Bortz DM; Carlton EJ
    Ann Am Thorac Soc; 2020 Oct; 17(10):1204-1206. PubMed ID: 32610024
    [No Abstract]   [Full Text] [Related]  

  • 46. Emerging Lessons From COVID-19 Response in New York City.
    Chokshi DA; Katz MH
    JAMA; 2020 May; 323(20):1996-1997. PubMed ID: 32453355
    [No Abstract]   [Full Text] [Related]  

  • 47. How TB and COVID-19 compare: an opportunity to integrate both control programmes.
    Echeverría G; Espinoza W; de Waard JH
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):971-974. PubMed ID: 33156768
    [No Abstract]   [Full Text] [Related]  

  • 48. Addressing COVID-19 in Afghanistan: What are the efforts and challenges?
    Lucero-Prisno DE; Ahmadi A; Essar MY; Lin X; Adebisi YA
    J Glob Health; 2020 Dec; 10(2):020341. PubMed ID: 33110541
    [No Abstract]   [Full Text] [Related]  

  • 49. A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic.
    Louie JK; Reid M; Stella J; Agraz-Lara R; Graves S; Chen L; Hopewell P
    Int J Tuberc Lung Dis; 2020 Aug; 24(8):860-862. PubMed ID: 32912395
    [No Abstract]   [Full Text] [Related]  

  • 50. COVID-19 in Myanmar: Spread, actions and opportunities for peace and stability.
    Oo MM; Tun NA; Lin X; Lucero-Prisno DE
    J Glob Health; 2020 Dec; 10(2):020374. PubMed ID: 33110565
    [No Abstract]   [Full Text] [Related]  

  • 51. SARS-CoV-2 From the Trenches: A Perspective From New York City.
    Gozansky EK; Moore WH
    AJR Am J Roentgenol; 2020 Jul; 215(1):27-28. PubMed ID: 32301630
    [No Abstract]   [Full Text] [Related]  

  • 52. Precautions, Utilization of Personal Protective Equipment, and Conservation Strategies During the COVID-19 Pandemic.
    Sampathkumar P; Beam E; Breeher LE; O'Horo JC
    Mayo Clin Proc; 2020 Sep; 95(9S):S11-S13. PubMed ID: 32807520
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID-19 in Africa: community and digital technologies for tuberculosis management.
    Koura KG; Harries AD; Fujiwara PI; Dlodlo RA; Sansan EK; Kampoer B; Affolabi D; Combary A; Mbassa V; Gando H; Bangoura A; Assao M; Gning B; Dogo MF; Fiogbé A; Bridgen G
    Int J Tuberc Lung Dis; 2020 Aug; 24(8):863-865. PubMed ID: 32912396
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Stewart R; El-Harakeh A; Cherian SA;
    Lancet; 2020 Nov; 396(10262):1539-1541. PubMed ID: 33096041
    [No Abstract]   [Full Text] [Related]  

  • 55. Early lessons from a second COVID-19 lockdown in Leicester, UK.
    Nazareth J; Minhas JS; Jenkins DR; Sahota A; Khunti K; Haldar P; Pareek M
    Lancet; 2020 Jul; 396(10245):e4-e5. PubMed ID: 32622374
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 in Greece: People take precedence over economics.
    Papadimos TJ
    J Glob Health; 2020 Dec; 10(2):020337. PubMed ID: 33110537
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-19 in Malaysia: Crucial measures in critical times.
    Ganasegeran K; Ch'ng ASH; Looi I
    J Glob Health; 2020 Dec; 10(2):020333. PubMed ID: 33110533
    [No Abstract]   [Full Text] [Related]  

  • 58. Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City.
    Burzynski J; Macaraig M; Nilsen D; Schluger NW
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):735-736. PubMed ID: 32718411
    [No Abstract]   [Full Text] [Related]  

  • 59. Social Distancing for COVID-19 and Diagnoses of Other Infectious Diseases in Children.
    Hatoun J; Correa ET; Donahue SMA; Vernacchio L
    Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32879032
    [No Abstract]   [Full Text] [Related]  

  • 60. Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia.
    Adikari DH; Kushwaha VV; Jepson NS
    Heart Lung Circ; 2020 Aug; 29(8):1109-1111. PubMed ID: 32653299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.